The preliminary scientific programme of 2025 at a glance

Plenary Sessions

Translating ADHD research to clinical world

What clinicians need to know about ADHD genetics?
Non-pharmacological treatment for ADHD: what is almost there?
Digital solutions in the assessment and treatment of ADHD: What already helps clinicians?

ADHD and trauma across the lifespan

What should we make of the reported link between ADHD and maltreatment?
Understanding ADHD in the context of genetic trauma predictors
Trauma recovery for ADHD with adverse childhood experiences - the work of trauma-focused psychotherapy in the perspective of adaptive information processing

Are ADHD medication safe? New data of long-term studies

Long-term medication for ADHD trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-years outcomes of the ADHD Drugs Use Chronic Effects (ADDUCE) study
ADHD Medications Use and Risks of mortality and unintentional injuries: A population-based cohort study

Adult ADHD: Essential insights every health professional must know

US guidelines for Adult ADHD
Can telepsychiatry help with ADHD assessment and treatment?
The TIMESPAN consortium: ADHD medication discontinuation and persistence in adulthood

Pro-and-Con-Debate

PC-01 | Does cognitive behavioral therapy adversely encourage patients with ADHD to mask their true selves?

Hot Topic Sessions

The lancet psychiatry series on ADHD

Current evidence and gaps on global ADHD and treatment epidemiology
What are the real-world long-term impacts of ADHD and its treatment: clinical, societal, and economic, and political implications
Barriers and facilitators for improving equity of access to ADHD care
Psychoeducation and advocacy

ADHD and global crises

Prenatal exposure to a natural disaster and early development of psychiatric disorders during the preschool years: stress in pregnancy study
Prevalence of mental health disorders among Immigrant, Refugee, and Nonimmigrant children and youth in British Columbia, Canada
Is there a relationship between ADHD and COVID-19 prevalence and mortality indices? An analysis of data from 156 countries
ADHD and climate change

Navigating ADHD in the perinatal period

ADHD medication use during pregnancy: Balancing benefits and risks
Short and long-term outcomes for infants exposed to ADHD medications in utero
Maternal mental health in the perinatal period: Challenges and strategies for women with ADHD
It’s all in your head: Hormonal changes across the female reproductive life

Inflammation and ADHD: The neurobiological mechanisms and clinical associations

Understanding the link between inflammation and ADHD: A current review of factors and mechanisms
Association of maternal autoimmune disease with ADHD in children
Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation
ADHD has a state-dependent association with asthma: The role of systemic inflammation in a populations-based birth cohort followed from childhood to adult

Should I need to worry about cardiovascular risks outcomes in my patients with ADHD treated with psychostimulants?

ADHD medications and long-term risk of cardiovascular diseases
Long-term cardiovascular safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the ADHD Drugs Use Chronic Effects (ADDUCE) study
ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): A multi-centre prospective cohort study
Comparative cardiovascular side effects of medications for ADHD in children, adolescents and adults: Systematic review and network meta-analysis

ADHD: Why are we waiting and what are you going to do about this?

Experiences of being on a waiting list and ideas on what might help
Waiting for Godot: Can technology help expedite ADHD diagnosis?
Should non-stimulants be the first medication option for adult ADHD? Lessons from a nurse-led primary-care service
ADHD in Sweden: Policy impacts on waiting lists

Multi-component cognitive behavioural therapy for ADHD: From preschool to adulthood

New forest parenting program for preschool children with ADHD in China
Executive skills training (multi-component cognitive behavioral therapy to both children and parents) for 6-12 children with ADHD: Face to face and on-line, first dosage and second dose
Cognitive-behavioral treatments for adolescents with ADHD: A systematic review of the literature
Cognitive-behavioral treatments for adults with ADHD: Systematic review with meta-analysis

Neurodiversity approach: Evidence for positive and strength focused aspects in ADHD

Positive attitudes towards ADHD among diagnosed individuals: Divergent influences across symptoms
Quantification of potential strengths in adults with ADHD
Distracted, hyperactive, and thriving: Factors supporting successful functioning in ADHD across the adult lifespan
I would never give up my ADHD” – high-functioning ADHD

Clinical dilemmas in treating patients with medication

What makes and how to approach ADHD complex cases?
How far should we go with stimulants doses in ADHD treatment?
Are drug holidays a valid strategy in ADHD treatment
Treating ADHD refractory cases

ADHD in college-aged adults

Why focusing attention on ADHD is integral to porting student mental health and academic success in South Africa Universities
ADHD in college students with sexual/gender minority identities
How effective and specific is extended time for college students? A randomized clinical trial
Cognitive-behavioral intervention to treat executive dysfunction in college students with ADHD

Female ADHD and the impact of hormones on mood and health across the lifespan

Hormonal effects on ADHD across the menstrual cycle and its cognitive and affective mechanisms
Executive dysfunctions during menopausal transition in women with ADHD
Female Specific Therapy for Women with ADHD (including premenstrual dose increase of stimulant medication, and group therapy for women with ADHD based on awareness of the impact of the cycle on their symptoms)
First data on self-efficacy and empowerment through self-monitoring of hormonal changes and ADHD-symptoms in women with ADHD

Novel biological targets and treatment approaches in ADHD

Patients in a dish- in vitro models as tools to investigate the etiology of ADHD, leading to new treatment options
The impact of the gut microbiome in the pathogenesis of ADHD and therapeutic approaches targeting the gut microbiome
Transcranial direct current stimulation as an option to normalize inhibitory-excitatory dysbalance in ADHD patients
Targeting right prefrontal cortex with fMRI-Neurofeedback and brain stimulation in ADHD

Assessment and management of ADHD in autism spectrum disorders

The neuroanatomical substrates of autism and ADHD and their link to putative genomic underpinnings
ADHD and autism symptoms in youth: A network analysis
Assessing the contribution of measures of attention and executive function to diagnosis of ADHD or autism
Guidance for identification and treatment of individuals with ADHD and autism spectrum disorder based upon expert consensus

ADHD coaching on the rise: Understanding coaches and their role in support

Results from the U.S. National Survey on ADHD coaching
Results from the Australian National Survey on ADHD coaching
Understanding recent trends in ADHD coaching
Building ADHD coaching guidelines

ADHD and substance use disorders

ADHD and substance use disorders: A frequent comorbidity
The CADDRA ADHD and Substance Use Program
ADHD and substance use disorder treatment guidelines
Psychostimulant medication for ADHD and risk of harmful substance use and diversion: Adolescent attitudes and long-term outcomes and physician clinical practice strategies

Two treatments better than one? Investigating combined treatments for childhood ADHD

Unguided parent mediated self-help interventions for childhood ADHD with or without medication
Treating parents with ADHD and their young children in urban pediatric primary care: The TPAC hybrid effectiveness-implementation study
Investigating a combined treatment approach to equip parents and teachers to support children with ADHD in Japan
The future of combined treatment: What do we know about sequencing treatments for ADHD?

Clinical perspectives on ADHD and antisocial behavior: Risks, strategies, and outcomes

ADHD and intimate partner violence
ADHD, sexuality and risk for breaking rules
Predictors for offending in people with ADHD
Therapeutic options for offenders with ADHD

Is physical activity a treatment option for ADHD?

The current state of research on exercise effects in children and adolescents as well as in adults with ADHD
Acute effects of physical activity in young people with ADHD
START - physical exercise and person-centred cognitive skills training as treatment for adult ADHD: Protocol for a randomized controlled trial
The impacts of a combined exercise on executive function in children with ADHD: A randomized controlled trial

Driving infractions and crashes in adults with ADHD vs. control subjects: Role of ADHD persistence, comorbidities and medication treatment

Driving infractions and crashes in Adults vs. controls followed prospectively in the Multisite Multimodal study on ADHD (MTA)
Double-blind placebo controlled simulated driving study of adults with ADHD
Observational data on traffic behaviour in individuals with ADHD and on effects of medication

Young Scientists' Sessions

Early Career Scientist Award symposium dedicated to Joseph Sergeant

Early Career Scientist Award Symposium dedicated to Joseph Biedermann